Abstract
An increase in the incidence of breast cancer in women aged <40 years has been reported in recent years. Increased incidence could be partly explained by subtle detection biases, but the role of other risk factors cannot be ruled out. The purpose of the present study was to investigate the changes in temporal trends in breast cancer incidence in European women aged 20–39 years at diagnosis. Age specific breast cancer incidence rates for 17 European Cancer Registries were retrieved for the calendar period 1995–2006. Cancer registries data were pooled to reduce annual fluctuations present in single registries and increase incidence rates stability. Regression models were fitted to the data assuming that the number of cancer cases followed the Poisson distribution. Mean annual changes in the incidence rate (AIC) across the considered time window were calculated. The AIC estimated from all European registries was 1.032 (95 % CI = 1.019–1.045) and 1.014 (95 % CI = 1.010–1.018) in women aged 20–29 and 30–39 years old at diagnosis, respectively. The major change was detected among women aged 25–29 years at diagnosis: AIC = 1.033 (95 % CI = 1.020–1.046). The upward trend was not affected when registries with high or low AIC were removed from the analysis (sensitivity analysis). Our findings support the presence of an increase in the incidence of breast cancer in European women in their 20s and 30s during the decade 1995–2006. The interpretation of the observed increase is not straightforward since a number of factors may have affected our results. The estimated annual increase in breast cancer incidence may result in a burden of the disease that is important in terms of public health and deserves further investigation of possible risk factors.
Similar content being viewed by others
References
Cancer incidence in five continents. Volume VIII (2000) IARC Sci Publ 155:1–781
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592
Karim-Kos HE, de VE, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44:1345–1389
Jatoi I, Anderson WF, Rao SR, Devesa SS (2005) Breast cancer trends among black and white women in the United States. J Clin Oncol 23:7836–7841
Fuglede N, Langballe O, Svendsen AL, Tjonneland A, Dalton SO, Johansen C (2006) Development in incidence of breast cancer in non-screened Danish women, 1973–2002: a population-based study. Int J Cancer 118:2366–2369
Otten JD, Broeders MJ, Fracheboud J, Otto SJ, de Koning HJ, Verbeek AL (2008) Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975–2006. Int J Cancer 123:1929–1934
Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9:R28
Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670–1674
Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 107:427–430
Kumle M (2008) Declining breast cancer incidence and decreased HRT use. Lancet 372:608–610
Allemand H, Seradour B, Weill A, Ricordeau P (2008) Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer 95:11–15
Ponti A, Rosso S, Zanetti R, Ricceri F, Tomatis M, Segnan N (2007) Re: Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1817–1818
Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E (2002) Use of oral contraceptives and breast cancer risk: the Norwegian–Swedish women’s lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev 11:1375–1381
Louwman WJ, Voogd AC, van Dijck JA, Nieuwenhuijzen GA, Ribot J, Pruijt JF, Coebergh JW (2008) On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975–2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control 19:97–106
Bouchardy C, Fioretta G, Verkooijen HM, Vlastos G, Schaefer P, Delaloye JF, Neyroud-Caspar I, Balmer MS, Wespi Y, Forni M et al (2007) Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer 96:1743–1746
Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100:1643–1648
Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint A, Kotlum JE, Olafsdottir E, Pukkala E, Storm HH (2010) NORDCAN: a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 49:725–736
Lindsey JK (1995) Modelling frequency and count data. Oxford University Press, Oxford
Leyland AH, Goldstein H (2001) Multilevel modelling of health statistics. Wiley, Chichester
Cleveland WS, Devlin SJ (1988) Locally-weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc 83:596–610
Stata statistical sofware (Release 11) (2009) StataCorp LP, College Station
Kelsey JL, Gammon MD (1991) The epidemiology of breast cancer. CA Cancer J Clin 41:146–165
Hery C, Ferlay J, Boniol M, Autier P (2008) Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 19:1187–1194
Colonna M, Delafosse P, Uhry Z, Poncet F, Arveux P, Molinie F, Cherie-Challine L, Grosclaude P (2008) Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983–2002. Breast 17:289–292
IARC handbooks of cancer prevention: volume 7. Breast Cancer Screening (2002) IARC Sci Publ 1–14
Seradour B, Allemand H, Weill A, Ricordeau P (2009) Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. Bull Cancer 96:E1–E6
Li CI, Daling JR (2007) Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev 16:2773–2780
Parkin DM (2009) Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? Eur J Cancer 45:1649–1653
Pollan M, Michelena MJ, Ardanaz E, Izquierdo A, Sanchez-Perez MJ, Torrella A (2010) Breast cancer incidence in Spain before, during and after the implementation of screening programmes. Ann Oncol 21(Suppl 3): iii97–iii102
Glass AG, Lacey JV Jr, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99:1152–1161
Anders CK, Johnson R, Litton J, Phillips M, Bleyer A (2009) Breast cancer before age 40 years. Semin Oncol 36:237–249
Han W, Kang SY (2010) Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 119:193–200
Levi F, Te VC, Maspoli M, Randimbison L, Bulliard JL, La Vecchia C (2007) Trends in breast cancer incidence among women under the age of forty. Br J Cancer 97:1013–1014
Cancer Incidence in Belgium, 2004–2005, Belgian Cancer Registry, Brussels (2008). www.coldfusionwebhostings.be/PSK/Upload/GENERAL//Brochures/KIB2004-2005/CancerInc_book.pdf. Accessed 26 Jan 2012
Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, Chen W, Stampfer MJ, Willett WC (2010) Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiol Biomarkers Prev 19(10): 2496–2502
Gabriel CA, Domchek SM (2010) Breast cancer in young women. Breast Cancer Res 12:212
Yankaskas BC (2005) Epidemiology of breast cancer in young women. Breast Dis 23:3–8
Pollan M (2010) Epidemiology of breast cancer in young women. Breast Cancer Res Treat 123(Suppl 1):3–6
Colditz GA, Sellers TA, Trapido E (2006) Epidemiology: identifying the causes and preventability of cancer? Nat Rev Cancer 6:75–83
Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ (2008) Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence. Clin Breast Cancer 8:334–342
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement (2009) Ann Intern Med 151: 236–716
Acknowledgments
Dr. Luigina Bonelli, Prevenzione Secondaria e Screening, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy, for valuable comments.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
The members of AIRTUM Working Group are given in Appendix.
Appendix
Appendix
M. Federico, Registro Tumori di Modena, Italy; L. Mangone, Registro Tumori Reggiano, Italy; M. Michiara, Registro Tumori della Provincia di Parma, Italy; M. Fusco, Registro Tumori di Napoli, Italy; E. Crocetti, Banca dati AIRTUM, Unità Operativa di Epidemiologia Clinica e Descrittiva, ISPO, Italy.
Rights and permissions
About this article
Cite this article
Merlo, D.F., Ceppi, M., Filiberti, R. et al. Breast cancer incidence trends in European women aged 20–39 years at diagnosis. Breast Cancer Res Treat 134, 363–370 (2012). https://doi.org/10.1007/s10549-012-2031-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-012-2031-7